Emerging Biopharma

Biotech

Drug discovery biotech Vyant preps to wind down operations

Vyant Bio is winding down operations, including reducing its workforce, pursuing strategic alternatives and saying goodbye to CEO John Roberts.
Annalee Armstrong Feb 3, 2023 10:14am

Days after halting leukemia drug, Magenta to close its doors

Feb 2, 2023 5:06pm

Purple snags Immunorizon's tri-specific antibodies in small M&A

Feb 2, 2023 10:20am

Layoffs still battering biotech, with Big Pharmas piling on pain

Feb 1, 2023 10:50am

More layoffs at Instil as cell therapy production shifts to UK

Feb 1, 2023 10:15am

Despite blockbuster Altos funds, longevity investment falls $1B

Jan 31, 2023 11:28am
More News

UniQure snags rare ALS therapy from Apic Bio for $10M upfront

Jan 31, 2023 10:45am

Structure finalizes $111M IPO; Intensity plots offering

Jan 30, 2023 10:59am

Fierce Biotech Fundraising Tracker: Ribon, Grey Wolf and more

Jan 30, 2023 9:36am

10 top M&A targets in biotech for 2023

Jan 30, 2023 3:00am